Amifostine promotes hemopoietic progenitor mobilization and growth in patients with myelodysplastic syndrome.

被引:0
|
作者
Lerza, R [1 ]
Botta, M [1 ]
Arboscello, E [1 ]
Clavio, M [1 ]
Miglino, M [1 ]
Mencoboni, M [1 ]
Bogliolo, G [1 ]
Pannacciulli, I [1 ]
机构
[1] Univ Genoa, Dipartimento Med & Specialita Med, Genoa, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
175
引用
收藏
页码:82 / 82
页数:1
相关论文
共 50 条
  • [31] Continuous oral Lonafarnib (SarasarTM) for the treatment of patients with myelodysplastic syndrome.
    Feldman, EJ
    Cortes, J
    Holyoake, TL
    Simonsson, B
    De Angelo, DJ
    Lipton, JH
    Turner, AR
    Baccarani, M
    Barker, J
    Guilhot, F
    Petersdorf, S
    Silver, RT
    Wilson, JM
    Sugrue, M
    List, AF
    [J]. BLOOD, 2003, 102 (11) : 421A - 421A
  • [32] Amifostine exerts anti-angiogenic activity and suppresses vascular endothelial growth factor secreted by hemopoietic stem/progenitor cells
    Akel, SM
    Atoum, MF
    Saleh, SA
    Awadallah, SM
    [J]. SAUDI MEDICAL JOURNAL, 2005, 26 (10) : 1523 - 1528
  • [33] Effect of SCF in vitro stimulation on hemopoietic progenitor cells (HPC) from patients with myelodysplastic syndromes: Comparison with other growth factors.
    Novelli, EM
    Ruggieri, L
    Camba, I
    [J]. BLOOD, 1996, 88 (10) : 3560 - 3560
  • [34] Circulating Cytokine Profiles of Patients with Acquired Aplastic Anemia and Myelodysplastic Syndrome.
    Feng, Xingmin
    Scheinberg, Phillip
    Wu, Colin O.
    Samsel, Leigh
    Nunez, Olga
    Prince, Courtney
    Weinstein, Barbara
    Ganetzky, Rebecca D.
    McCoy, J. Philip
    Maciejewski, Jaroslaw P.
    Young, Neal S.
    [J]. BLOOD, 2008, 112 (11) : 380 - 381
  • [35] Deleted mutation of GSTT-1 gene in patients with myelodysplastic syndrome.
    Maeda, Y
    Sumimoto, Y
    Nawata, H
    Sono, H
    Matsuda, M
    Tatsumi, Y
    Horiuchi, F
    Kanamaru, A
    [J]. BLOOD, 1998, 92 (10) : 252B - 252B
  • [36] Filamentous fungi infection in patients with myelodysplastic syndrome. A report of twelve cases
    Mele, L
    Ricci, P
    Nosari, A
    Tonso, A
    Fianchi, L
    Cudillo, L
    Pagano, L
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (07) : 1421 - 1425
  • [37] Micrornas Analysis in Patients with Myelodysplastic Syndrome. Possible Implications in Risk Stratification
    Kontandreopoulou, Christina-Nefeli
    Syriopoulou, Stavroula
    Diamantopoulos, Panagiotis T.
    Giannakopoulou, Nefeli
    Vlachopoulou, Dimitra
    Katsiampoura, Panagiota
    Stafylidis, Christos
    Dimou, Maria
    Galanopoulos, Athanasios
    Papageorgiou, Sotirios
    Hatzimichael, Eleftheria
    Pappa, Vassiliki
    Ioannis, Kotsianidis
    Symeonidis, Argiris
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    [J]. BLOOD, 2022, 140 : 6958 - 6959
  • [38] Exercise promotes endothelial progenitor cell mobilization in patients with chronic heart failure
    Mitsiou, Georgios
    Karatzanos, Eleftherios
    Smilios, Ilias
    Psarra, Katherina
    Patsaki, Irini
    Douda, Helen T.
    Ntalianis, Argyrios
    Nanas, Serafeim
    Tokmakidis, Savvas P.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (18) : E24 - E27
  • [39] In Vitro Deprivation of CD8+CD57+t Cells Promotes the Malignant Growth of Bone Marrow Stem/Progenitor Cells in Patients with Myelodysplastic Syndrome
    Zhang, Qianqiao
    Li, Xiao
    Zhang, Zheng
    Xu, Feng
    He, Qi
    Wu, Lingyun
    Chang, Chunkang
    [J]. BLOOD, 2009, 114 (22) : 701 - 701
  • [40] Do patients with low-grade myelodysplastic syndrome (MDS) mobilise normal hemopoietic progenitors?
    Mijovic, A
    Delforge, M
    Sekhavat, M
    Czepulkowski, B
    Ghulam, MJ
    [J]. BLOOD, 2000, 96 (11) : 149A - 149A